Dr. Priscilla Davidson Negraes has a Bachelor degree in Biological Sciences at State University of Londrina (Brazil), where she also got her Master’s degree in Genetics and Breeding by evaluating the antimutagenic effect of natural compounds. She completed her Ph.D. in Genetics at São Paulo State University (Brazil), after studying the relationship and relevance of epigenetics for the prognosis of human bladder cancer. Dr. Negraes joined the Neuroscience and Stem Cell fields during her postdoc at University of São Paulo (Brazil), when she worked on neural differentiation of stem cells and the characterization of neurotransmitters systems during cell fate determination. Next, she became a Visiting Scholar at University of California San Diego (USA), and started to model human neurological diseases using induced pluripotent stem cells. As a result of these experiences, Dr. Negraes developed an extensive knowledge in cell culture, cellular and molecular biology, and neural differentiation of stem cells. Currently, she is a reviewer for many scientific journals and works on modelling neurodevelopmental disorders to ultimately disclose new therapies and improve patients’ quality of life.Prof. Henning Ulrich studied Biology at the Universities of Hamburg and Kiel (Germany) and performed his master thesis in Biochemical Parasitology, followed by a PhD. in Biochemistry and Neuroscience at the University of Hamburg, Germany. He completed his training by postdoctoral research at the Center of Molecular Neurobiology at the University of Hamburg and Cornell University, NY, the latter one financed by a fellowship of the American Heart Association. He came to the Institute of Chemistry at the Sao Paulo University as a visiting scientist, where he was then appointed as faculty member. Here he habilitated in Biochemistry, is currently Associate Professor and head of the laboratory of neuroscience, working on stem cells and mechanisms of neurogenic differentiation of diverse types of stem cells and stem cell techniques for possible therapeutic use of neurodegenerative disease. Dr. Ulrich has published more than 100 papers in peer-reviewed journals (H-factor of 25, more than 1800 citations), 3 books (two of them published with Springer), 14 book chapters and participated in three patents. His research results were commented in major Brazilian newspapers. His is acting as editorial board member of renowned journals, Associate Editor of Cytometry A and Academic Editor of PLoS ONE.
